Recital 7, Regulation (EU) 2024/1037

In forcesince 9 Apr 2024

In its scientific opinion, the Authority concluded that the novel food, monosodium salt of L-5-methyltetrahydrofolic acid, is safe under the applicant’s proposed conditions of use, as long as the combined intake of the novel food and other sources of folate under their authorised conditions of use is below the tolerable upper intake levels (UL) established for the different age groups of the general population. The Authority also considers that the novel food is a source from which folate is bioavailable. Therefore, that scientific opinion gives sufficient grounds to establish that monosodium salt of L-5-methyltetrahydrofolic acid, when used under the proposed conditions of use fulfils the conditions for its placing on the market in accordance with Article 12(1) of Regulation (EU) 2015/2283.